| |
| |
|
| Insider
Information: |
Loberg Michael D |
| Relationship: |
Director |
| City: |
Bedford |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
9,138 |
|
|
Indirect Shares
|
81,790 |
|
|
| Direct
Value |
$110,000 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
90,928 |
|
|
| Total
Value |
$110,000 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
AMAG Pharmaceuticals Inc |
AMAG |
Director |
2006-06-08 |
8,000 |
2006-06-07 |
0 |
Premium* |
|
|
Arqule Inc |
ARQL |
Director |
2020-01-16 |
0 |
2007-08-17 |
0 |
Premium* |
|
|
Igm Biosciences, Inc. |
IGMS |
Director |
2023-09-29 |
1,138 |
2023-09-29 |
81,790 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
262 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 11 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARQL |
Arqule Inc |
Director |
– • – |
2007-10-25 |
4 |
B |
$7.80 |
$499 |
D/D |
64 |
752 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2012-02-18 |
4 |
A |
$7.83 |
$2,498 |
D/D |
319 |
71,275 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2012-02-01 |
4 |
A |
$7.95 |
$1,988 |
D/D |
250 |
71,025 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2019-09-18 |
4 |
B |
$18.57 |
$92,867 |
D/D |
5,000 |
35,264 |
2.39 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-09-29 |
4 |
B |
$19.62 |
$114,213 |
I/I |
5,821 |
35,305 |
2.1 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-09-27 |
4 |
B |
$19.99 |
$10,137 |
I/I |
507 |
23,312 |
2.1 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2020-01-16 |
4 |
D |
$20.00 |
$3,761,240 |
D/D |
(188,062) |
0 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-09-28 |
4 |
B |
$20.97 |
$129,403 |
I/I |
6,172 |
29,484 |
2.1 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-04-01 |
4 |
B |
$23.00 |
$499,997 |
I/I |
21,739 |
21,739 |
2.1 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2006-06-05 |
4 |
S |
$24.02 |
$192,127 |
D/D |
(8,000) |
0 |
|
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2006-06-08 |
4 |
S |
$24.02 |
$564,374 |
D/D |
(23,500) |
0 |
|
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2006-06-07 |
4 |
S |
$24.28 |
$764,820 |
D/D |
(31,500) |
0 |
|
- |
|
262 Records found
|
|
Page 11 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
